Infant Parenteral Nutrition Remains a Significant Source for Aluminum Toxicity

Amanda R Hall1, Chris J Arnold2, Grant G Miller1

  • 11 Department of Surgery, University of Saskatchewan, Saskatoon, Canada.

Insights

Aluminum contamination in infant parenteral nutrition (PN) is nearly three times the recommended limit. This study found significant links between aluminum levels and calcium gluconate and phosphate in PN, highlighting the need for further investigation to reduce infant exposure.

Area of Science:

  • Neonatal Medicine
  • Clinical Chemistry
  • Toxicology

Background:

  • Aluminum toxicity poses risks including anemia, bone defects, and liver disease.
  • Aluminum is a common contaminant in parenteral nutrition (PN), particularly for infants.
  • Assessing aluminum levels in infant PN is crucial for patient safety.

Purpose of the Study:

  • To evaluate current aluminum contamination levels in infant PN.
  • To identify potential sources and correlations of aluminum in PN formulations.
  • To compare measured aluminum levels with established safety guidelines.

Main Methods:

  • Collected 30 discarded infant PN samples from a neonatal intensive care unit.
  • Analyzed aluminum content using inductively coupled plasma mass spectrometry.
  • Compared aluminum levels with PN components using regression and ANOVA.

Main Results:

  • Mean aluminum contamination was 14.02 mcg/kg/d, exceeding the <5 mcg/kg/d FDA guideline.
  • Significant correlations found between aluminum and calcium gluconate (P < .0001) and phosphate (P = .05).
  • No association observed between aluminum levels and infant weight in this cohort.

Conclusions:

  • Infant PN exhibits aluminum contamination significantly above recommended levels.
  • Calcium gluconate and phosphate are likely contributors to aluminum contamination.
  • Further research is needed to pinpoint sources and reduce aluminum in infant PN.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
2.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
720
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443